| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 09/12/1996 | WO1996020199A3 Diclavulanate salt with a diamino ether and process of preparation |
| 09/12/1996 | CA2214726A1 Compositions and methods for stimulating antibody class switching |
| 09/12/1996 | CA2214723A1 Protection from viral infection via colonization of mucosal membranes with genetically modified bacteria |
| 09/12/1996 | CA2214589A1 Compositions and methods for the treatment and diagnosis of immune disorders |
| 09/11/1996 | EP0731168A1 MSRV-1 virus and pathogenic and/or infectious agent MSRV-2 associated with rheumatoid arthritis |
| 09/11/1996 | EP0731165A2 Human T-cell line infected with HIV-2 which secretes functionally intact HIV-2 GP160 |
| 09/11/1996 | EP0731109A1 Purification of D-factor |
| 09/11/1996 | EP0731099A1 N-(3-benzofuranyl)urea-derivatives |
| 09/11/1996 | EP0731088A2 Retroviral protease inhibitors |
| 09/11/1996 | EP0730650A1 Retroviral superantigens, superantigen peptides, and methods of use |
| 09/11/1996 | EP0730601A1 Compounds and pharmaceutical compositions for the treatment and prophylaxis of bacterial infections |
| 09/11/1996 | EP0730598A1 Hindered esters of rapamycin and their use as pharmaceuticals |
| 09/11/1996 | EP0730597A1 Heterocyclic esters of rapamycin and pharmaceutical compositions containing them |
| 09/11/1996 | EP0730591A1 Esters of substituted-hydroxyacetyl piperazine phenyl oxazolidinones |
| 09/11/1996 | EP0730587A1 3-aryl-2-isoxazolines as antiinflammatory agents |
| 09/11/1996 | EP0730579A1 Substituted indoles as phosphodiesterase type iv inhibitors |
| 09/11/1996 | EP0730470A1 Improved interferon polymer conjugates |
| 09/11/1996 | EP0730464A1 Composition comprising sulcralfate and an antimicrobial agent/ion-exchange resin complex |
| 09/11/1996 | EP0730462A1 Condensation polymer of an aromatic sulfonic acid and an aldehyde for inhibiting hiv infectivity |
| 09/11/1996 | EP0730459A1 The use of an ester of inositoltrisphosphate for the preparing of medicaments |
| 09/11/1996 | EP0730450A1 Plaster for treating nail mycoses |
| 09/11/1996 | EP0730408A1 Triazole phosphonate pesticides |
| 09/11/1996 | EP0534944B1 Antibodies specific for elam-1 and the use thereof |
| 09/11/1996 | EP0507861B1 Diaromatic substituted anti-aids compounds |
| 09/11/1996 | CN1130923A Salmonella vaccines |
| 09/11/1996 | CN1130906A Oxathiolanes, method for their preparation and pharmaceutical compositions containing same |
| 09/11/1996 | CN1130905A Process for making HIV protease inhibitors |
| 09/11/1996 | CN1130902A Substituted pyridines, process for producing them and their use as pesticides and fungicides |
| 09/11/1996 | CN1130898A Difluoro statone antiviral analogs |
| 09/11/1996 | CN1130873A Method of treating HIV with azaspiranes |
| 09/11/1996 | CN1130872A Use of benzydamine in treatment of pathological conditions caused by TNF |
| 09/11/1996 | CN1130871A Method of inhibiting replication of human immunodeficiency viruses with substituted azaspiranes |
| 09/11/1996 | CN1130532A Modulation of cellular activity |
| 09/11/1996 | CN1130506A Pharmaceutical formulations of cefaclor |
| 09/11/1996 | CA2170968A1 Preparation of d4t from 5-methyluridine |
| 09/10/1996 | US5554756 Amino acid derivatives |
| 09/10/1996 | US5554728 Lipid conjugates of therapeutic peptides and protease inhibitors |
| 09/10/1996 | US5554653 Inhibitors of HIV protease useful for the treatment of AIDS |
| 09/10/1996 | US5554596 Polymer with lignin units and lignoid units |
| 09/10/1996 | US5554538 DNA sequences derived from papillomavirus HPV-33 genome |
| 09/10/1996 | US5554524 More complex type retroviruses having mixed type LTR, and uses thereof |
| 09/10/1996 | US5554512 Isolated dna sequence encoding flt3 ligand polypeptide; expression vector comprising the sequence; host cell transformed or transfected with the vector; culture process for producing flt3-l polypeptide; nucleic acid sequences |
| 09/10/1996 | US5554371 Contains antigenic recombinant polypeptide with amino acid sequence corresponding to that of recombinant polypeptide produced by e. coli transformant atcc 68825; immunization process |
| 09/10/1996 | US5554150 Granulocyte colony-stimulating factor solution delivery method |
| 09/10/1996 | CA2171242A1 Msrv-1 virus and pathogenic and/or infective msrv-2 related to rhumatoid arthritis |
| 09/10/1996 | CA2038629C Oleandomycin oximes, preparation and use thereof |
| 09/10/1996 | CA2036507C 2'-deoxy-2'-methylidenecytidine dihydrate, methods for its production and compositions |
| 09/08/1996 | CA2171144A1 Human t-cell line infected with hiv-2 which secretes functionally intact hiv-2 gp160 |
| 09/07/1996 | CA2170824A1 N-(3-benzofuranyl)urea-derivatives |
| 09/06/1996 | WO1996027011A1 A method for making heteromultimeric polypeptides |
| 09/06/1996 | WO1996026950A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 09/06/1996 | WO1996026944A1 Clavulanic acid salts |
| 09/06/1996 | WO1996026943A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines |
| 09/06/1996 | WO1996026933A1 Novel selective inhibitors of viral or bacterial neuraminidases |
| 09/06/1996 | WO1996026926A1 Pyrazolotetracyclines |
| 09/06/1996 | WO1996026741A1 Hepatitis b vaccine |
| 09/06/1996 | WO1996026738A1 Pharmaceutical compositions for controlled release of soluble receptors |
| 09/06/1996 | WO1996026735A1 Method for stimulating an immune response |
| 09/06/1996 | WO1996026734A1 Antiviral combinations of bch-189 and ritonavir |
| 09/06/1996 | WO1996026724A1 Pharmaceutical compositions containing a benzydamine or its salt and an antimicrobial agent |
| 09/06/1996 | CA2213621A1 Antiviral combinations of bch-189 and ritonavir |
| 09/06/1996 | CA2213563A1 Clavulanic acid salts |
| 09/06/1996 | CA2212345A1 Derivatives of 3-pyrrolidylidene-2-one-cephalosporines |
| 09/06/1996 | CA2189358A1 Increased bioavailability of biologically active compounds by linking to polypyrrolecarboxamidonaphthalene derivatives |
| 09/04/1996 | EP0729974A1 Cyclic polypeptide with antibiotic activity and a process for preparation thereof |
| 09/04/1996 | EP0729961A1 Clavulanic acid salts |
| 09/04/1996 | EP0729509A1 Vaccine against mumps containing a jeryl-lynn virus strain |
| 09/04/1996 | EP0729467A1 Prodrugs of an inhibitor of hiv protease |
| 09/04/1996 | EP0729466A1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 09/04/1996 | EP0729465A1 Pyrone derivatives as protease inhibitors and antiviral agents |
| 09/04/1996 | EP0729464A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| 09/04/1996 | EP0729463A1 5,6-dihydropyrone derivatives as protease inhibitors and antiviral agents |
| 09/04/1996 | EP0504184B1 Active agent against retrovirus group viruses, compositions containing same and their use |
| 09/04/1996 | CN1130379A Substituted oxazine and thiazine oxazolidinone antimicrobials |
| 09/03/1996 | US5552541 Haptenic probes for detecting capture polynucleotides |
| 09/03/1996 | US5552536 DNA encoding precursor of interleukin-1 beta converting enzyme - related cysteine proteinase III (ice rel-III) |
| 09/03/1996 | US5552521 Process for preparing certain aza cyclohexapeptides |
| 09/03/1996 | US5552520 Such as somatostatin analogs or bombesin analogs |
| 09/03/1996 | US5552430 Antiretroviral compounds |
| 09/03/1996 | US5552405 Substituted pyrrolidine derivatives as HIV protease inhibitors |
| 09/03/1996 | US5552384 Antiherpes compositions and method of use |
| 09/03/1996 | US5552311 Purine nucleoside phosphorylase gene therapy for human malignancy |
| 09/03/1996 | US5552146 Methods and compositions relating to useful antigens of Moraxella catarrhalis |
| 09/03/1996 | CA2059632C Reveromycin a, method for preparing same, and antitumor agent and antifungal agent comprising the same |
| 09/03/1996 | CA1338571C 3-(substituted)-1-carba (dethia)-3-cephems and cephalosporins and a process for production therefor |
| 09/02/1996 | CA2170839A1 Bacterial preparations, method for producing same, and their use as vaccines |
| 08/29/1996 | WO1996026284A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |
| 08/29/1996 | WO1996026277A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 08/29/1996 | WO1996026275A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 08/29/1996 | WO1996026209A1 Stable hydrates of a cephalosporin chloride salt |
| 08/29/1996 | WO1996025942A1 Cochleate phospholipids in drug delivery |
| 08/29/1996 | WO1996025941A1 Modulators of regulatory proteins |
| 08/29/1996 | WO1996025936A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 08/29/1996 | WO1996019580A3 Telomerase protein component |
| 08/29/1996 | WO1996016675A3 Composition for prevention and treatment of hiv-1 infection comprising at least two different hiv-1 reverse transcriptase inhibitors |
| 08/29/1996 | CA2213484A1 Modulators of regulatory proteins |
| 08/29/1996 | CA2213135A1 2,6-diaryl pyridazinones with immunosuppressant activity |
| 08/29/1996 | CA2212870A1 Dna molecule encoding for cellular uptake of mycobacterium tuberculosis and uses thereof |
| 08/29/1996 | CA2211995A1 Polypeptides useful as immunotherapeutic agents and methods of polypeptide preparation |
| 08/29/1996 | CA2211435A1 Amplifier sequences derived from the desmin gene, vectors comprising same and uses thereof for producing proteins |